Trevi Therapeutics (TRVI) Depreciation & Amortization (CF) (2018 - 2026)
Trevi Therapeutics' quarterly Depreciation & Amortization (CF) came in at $34000.0 in Q1 2026, down 8.11% year-on-year from $37000.0 in Q1 2025, and up 9.68% quarter-over-quarter from $31000.0 in Q4 2025.
Trevi Therapeutics has reported Depreciation & Amortization (CF) for 9 years, with the latest figure at $34000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 8.11% year-over-year to $34000.0; the trailing twelve-month figure through Mar 2026 stood at $141000.0 (down 5.37% YoY), and the FY2025 full-year result was $144000.0, down 2.04% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $34000.0, up from $31000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $38000.0 in Q2 2024, with the low at $8000.0 in Q2 2022.
- Average Depreciation & Amortization (CF) over 5 years is $28882.4, with a median of $35000.0 recorded in 2023.
- Year-over-year, Depreciation & Amortization (CF) sank 33.33% in 2022 and jumped 325.0% in 2023.
- Tracing TRVI's Depreciation & Amortization (CF) over 5 years: stood at $15000.0 in 2022, then surged by 133.33% to $35000.0 in 2023, then rose by 8.57% to $38000.0 in 2024, then declined by 18.42% to $31000.0 in 2025, then gained by 9.68% to $34000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $34000.0 (Q1 2026), $31000.0 (Q4 2025), and $38000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - | 34,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34,000.00 |
| Mar 31, 2026 | 34,000.00 |
| Dec 31, 2025 | 31,000.00 |
| Dec 31, 2025 | 31,000.00 |
| Sep 30, 2025 | 38,000.00 |
| Sep 30, 2025 | 38,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Sep 30, 2024 | 36,000.00 |
| Sep 30, 2024 | 36,000.00 |
| Jun 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 38,000.00 |
| Mar 31, 2024 | 35,000.00 |
| Mar 31, 2024 | 35,000.00 |
| Dec 31, 2023 | 35,000.00 |
| Dec 31, 2023 | 35,000.00 |
| Sep 30, 2023 | 35,000.00 |
| Sep 30, 2023 | 35,000.00 |
| Jun 30, 2023 | 34,000.00 |
| Jun 30, 2023 | 34,000.00 |
| Mar 31, 2023 | 19,000.00 |
| Mar 31, 2023 | 19,000.00 |
| Dec 31, 2022 | 15,000.00 |
| Dec 31, 2022 | 15,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 11,000.00 |
| Mar 31, 2022 | 11,000.00 |
| Dec 31, 2021 | 12,000.00 |
| Dec 31, 2021 | 12,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 12,000.00 |
| Jun 30, 2021 | 12,000.00 |
| Mar 31, 2021 | 13,000.00 |
| Mar 31, 2021 | 13,000.00 |
| Dec 31, 2020 | 13,000.00 |
| Dec 31, 2020 | 13,000.00 |
| Sep 30, 2020 | 13,000.00 |
| Sep 30, 2020 | 13,000.00 |
| Jun 30, 2020 | 11,000.00 |
| Jun 30, 2020 | 11,000.00 |
| Mar 31, 2020 | 10,000.00 |
| Mar 31, 2020 | 10,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Sep 30, 2019 | 11,000.00 |
| Sep 30, 2019 | 11,000.00 |
| Jun 30, 2019 | 10,000.00 |
| Jun 30, 2019 | 10,000.00 |
| Mar 31, 2019 | 9,000.00 |
| Mar 31, 2019 | 9,000.00 |
| Dec 31, 2018 | 13,000.00 |
| Dec 31, 2018 | 13,000.00 |
| Sep 30, 2018 | 4,000.00 |
| Sep 30, 2018 | 4,000.00 |
| Jun 30, 2018 | 4,000.00 |
| Jun 30, 2018 | 4,000.00 |
| Mar 31, 2018 | 2,000.00 |
| Mar 31, 2018 | 2,000.00 |